These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2829615)
1. A phase II trial of oral melphalan in recurrent primary brain tumors. Chamberlain MC; Prados MD; Silver P; Levin VA Am J Clin Oncol; 1988 Feb; 11(1):52-4. PubMed ID: 2829615 [TBL] [Abstract][Full Text] [Related]
2. [Evolution of chemotherapy for malignant brain tumors]. Takeshima H; Kuratsu J No Shinkei Geka; 2003 Jul; 31(7):725-34. PubMed ID: 12884787 [No Abstract] [Full Text] [Related]
3. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience. Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501 [TBL] [Abstract][Full Text] [Related]
4. A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma. Pipas JM; Meyer LP; Rhodes CH; Cromwell LD; McDonnell CE; Kingman LS; Rigas JR; Fadul CE J Neurooncol; 2005 Feb; 71(3):301-5. PubMed ID: 15735921 [TBL] [Abstract][Full Text] [Related]
5. Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental models of human medulloblastoma. Friedman HS; Schold SC; Mahaley MS; Colvin OM; Oakes WJ; Vick NA; Burger PC; Bigner SH; Borowitz M; Halperin EC J Clin Oncol; 1989 Jul; 7(7):904-11. PubMed ID: 2738624 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of primary brain tumors. Levin VA Neurol Clin; 1985 Nov; 3(4):855-66. PubMed ID: 3001491 [TBL] [Abstract][Full Text] [Related]
7. Phase II study of cisplatin in recurrent astrocytomas in adults: a Southwest Oncology Group Study. Stewart DJ; O'Bryan RM; Al-Sarraf M; Costanzi JJ; Oishi N J Neurooncol; 1983; 1(2):145-7. PubMed ID: 6088711 [TBL] [Abstract][Full Text] [Related]
8. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129 [TBL] [Abstract][Full Text] [Related]
9. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas. Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913 [TBL] [Abstract][Full Text] [Related]
10. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas. Sipos L; Vitanovics D; Afra D Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767 [TBL] [Abstract][Full Text] [Related]
11. Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine. Prados M; Rodriguez L; Chamberlain M; Silver P; Levin V Neurosurgery; 1989 Jun; 24(6):806-9. PubMed ID: 2546093 [TBL] [Abstract][Full Text] [Related]
13. [Determination of the individual sensitivity of human glial tumors to the action of chemotherapeutic preparations]. Apshkalne DL; Kotel'nikov VM; Puryn'sh IZh; Safronov VA Zh Vopr Neirokhir Im N N Burdenko; 1979; (4):30-6. PubMed ID: 225913 [TBL] [Abstract][Full Text] [Related]
14. Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure. Newton HB; Junck L; Bromberg J; Page MA; Greenberg HS Neurology; 1990 Nov; 40(11):1743-6. PubMed ID: 2172864 [TBL] [Abstract][Full Text] [Related]
15. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group. Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175 [TBL] [Abstract][Full Text] [Related]
16. Intravenous carboplatin for recurrent malignant glioma: a phase II study. Yung WK; Mechtler L; Gleason MJ J Clin Oncol; 1991 May; 9(5):860-4. PubMed ID: 1849986 [TBL] [Abstract][Full Text] [Related]
17. Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study. Brandes AA; Ermani M; Turazzi S; Scelzi E; Berti F; Amistà P; Rotilio A; Licata C; Fiorentino MV J Clin Oncol; 1999 Feb; 17(2):645-50. PubMed ID: 10080610 [TBL] [Abstract][Full Text] [Related]
18. Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. Preul MC; Caramanos Z; Villemure JG; Shenouda G; LeBlanc R; Langleben A; Arnold DL Neurosurgery; 2000 Feb; 46(2):306-18. PubMed ID: 10690719 [TBL] [Abstract][Full Text] [Related]
19. Phase II study of weekly intravenous menogaril in the treatment of recurrent astrocytomas in adults. Stewart DJ; Hugenholtz H; DaSilva VF; Benoit BG; Richard MT; Verma S; Earhart R; Robillard L J Neurooncol; 1992 Jun; 13(2):183-8. PubMed ID: 1331346 [TBL] [Abstract][Full Text] [Related]
20. A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme. Aoki T; Mizutani T; Ishikawa M; Sugiyama K; Hashimoto N Int J Clin Oncol; 2003 Oct; 8(5):301-4. PubMed ID: 14586755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]